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Part	A	-	Study	protocol	
Study	Title:	 Resection	 of	 biliary	 mucinous	 cystic	 neoplasms:	 Study	 of	 a	 single	
institutional	cohort	and	a	literature	review	
Principal	investigators:	Profs	E	Jonas	and	JEJ	Krige		 	 	Co-investigator:	Dr	JC	Kloppers	
	
Introduction	and	background:	
Intrahepatic	 biliary	 cystadenoma	 was	 initially	 described	 in	 1887	 with	 the	 first	 resection	
performed	in	1892.	In	1958	Edmondson	defined	strict	criteria	as	definition	of	cystadenoma	
which	included	the	lesion	to	be	multilocular	with	ovarian-like	stroma.	In	1994	Devaney	et	al.	
evaluated	 the	 pathology	 of	 70	 cases	 and	 observed	 the	 presence	 of	 ovarian	 stroma	 to	 be	
inconsistent	 and	proposed	 that	 biliary	 cystadenomas	 could	occur	with	or	without	 ovarian	
stroma.1,2	The	World	Health	Organization	Classification	of	Tumours	3rd	Edition	published	in	
2000	 described	 the	 disease	 entity	 biliary	 cystadenomas	 and	 cystadenocarcinomas.3	 There	
however	 remains	confusion	 in	 the	 literature	and	biliary	cystadenomas	were	 reclassified	 in	
the	4th	Edition	published	in	2010	as	biliary	mucinous	cystic	neoplasms	(BMCNs),	either	non-
invasive	 or	 invasive.	 BMCNs	 have	 no	 biliary	 communication	 and	 should	 have	 ovarian-like	
stroma	to	confirm	the	diagnosis.4	Biliary	cystadenomas	are	 rare	and	account	 for	 less	 than	
5%	of	all	cystic	lesions.	As	more	incidental	simple	cysts	are	diagnosed,	this	number	is	likely	
to	shrink.5	
	
More	 than	90%	of	 all	 BCMNs	occur	 in	 females.	Many	 studies	with	more	 than	10	patients	
include	 only	 women.4,6	 This	 almost	 exclusive	 female	 predominance	 suggests	 a	 hormonal	
influence.	 The	 age	 of	 presentation	 is	 highly	 variable	 but	 peaks	 around	 the	 4th	 and	 5th	
decade.	Patients	may	be	asymptomatic	with	the	cystic	neoplasm	diagnosed	incidentally	on	
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imaging	or	during	surgery	for	a	different	indication.	It	is	likely	that	a	significant	percentage	
of	BCMNs	are	mistaken	for	simple	hepatic	cysts	and	left	untreated.7	
	
Formal	 surgical	 resection	 with	 negative	 margins	 remains	 the	 recommended	 treatment.	
Appropriate	 surgical	 stragegies	 include	 liver	 resection	 or	 enucleation	 depending	 on	 the	
individual	patient,	anatomic	position	of	the	cyst,	and	surgeon	experience.8,9	
	
BMCNs	are	complex	problems	and	should	be	the	primary	diagnostic	consideration	in	middle	
aged	women	who	have	well	 encapsulated	multilocular	 cystic	 liver	 tumours.	The	histologic	
classification	has	evolved	considerably	and	surgical	resection	still	offers	optimal	treatment.	
Due	 to	 the	 unpredictable	malignant	 risk	 and	 tendency	 for	 late	 recurrence,	 these	 patients	
also	need	long	term	follow	up.10,11	
	
Objectives:	
The	aim	is	to	study	the:	 	
1. The	profile	of	patients	with	a	BMCNs	
2. The	operative	procedure	and	outcomes	in	a	large	South	African	referral	centre.	
	
Methods:	
Data	from	a	departmental	and	faculty	registered	prospective	liver	resection	database	will	be	
used	 to	 identify	 patients	 who	 underwent	 surgery	 for	 BMCNs	 in	 the	 HPB	 Surgical	 Unit	 at	
Groote	 Schuur	 Hospital	 during	 a	 15	 year	 period	 (1999	 to	 2015).	 This	 registry	 has	 been	
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approved	by	the	Human	Research	Ethics	Committee	 (HREC)	 (R024/2014).	The	data	will	be	
retrospectively	analyzed.	
An	estimate	of	15	patients	will	be	evaluated.	Patient’s	age,	gender,	symptoms	and	signs	will	
be	recorded.	The	size	and	location	of	the	liver	lesion	will	be	studied.	
The	following	parameters	regarding	the	operative	procedure	will	be	collected:	
• Type	of	resection	(formal	liver	resection,	resection	by	enucleation,	partial	resection)	
• Use	of	inflow	occlusion	
• Need	for	intra–operative	transfusion	
• Frozen	section	taken	
• Drain	use	or	not	
• Operative	time	in	minutes	
• ICU	stay	in	days	and	hospital	stay	in	days	
• Final	histology		
• Outcome	and	follow	up	of	patient	
This	will	largely	be	a	descriptive	study	which	would	require	minimal	statistical	analysis.		
	
Ethical	considerations:	
Only	 data	 from	 the	 HREC	 approved	 database	 (R024/2014)	 will	 be	 used.	 No	 risks	 to	 the	
patients	 are	 anticipated	 and	 patient	 records	 will	 be	 treated	 confidentially	 with	 only	 the	
principal	investigator	having	access.	Any	reports	or	publications	resulting	from	the	research	
will	maintain	the	anonymity	of	the	individual	study	participants.	
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Budget:	
Apart	from	basic	stationery,	no	expenses	are	anticipated.	
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Part	B	-	Structured	literature	review		
Biliary	mucinous	cystic	neoplasms	of	the	liver	
Literature	search	strategy		
A	structured	literature	review	was	performed	searching	the	electronic	databases	of	Pubmed	
and	Google	Scholar	using	the	search	thread	(mucinous	biliary	cystic	neoplasms)	OR	(biliary	
cystadenoma)	OR	(biliary	cystadenocarcinoma)	OR	(ovarian	stroma).	Additional	manual	
searches	of	the	Cochrane	Library,	National	Comprehensive	Cancer	Network	guidelines	and	
World	Health	Organization	publications	were	also	performed.	References	were	cross	
checked.	Only	human	studies	in	English	were	included.	
	
Figure	1:	Algorithm	for	literature	search	
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Objectives	of	literature	review		
Liver	cysts	are	commonly	encountered	in	clinical	practice	and	with	the	widespread	use	of	
liver	ultrasound	and	cross	sectional	imaging	are	identified	as	an	incidental	finding	with	
increasing	frequency.1	The	differential	diagnosis	includes	a	spectrum	of	lesions,	from	benign	
lesions	with	little	clinical	significance	to	malignant	tumours.2	The	incidence	of	the	different	
cysts	depends	on	the	population	studied.	In	the	South	African	context	the	more	commonly	
encountered	cystic	lesions	are	simple	liver	cysts,	abscesses	and	hydatid	cysts.	Biliary	
mucinous	cystic	neoplasms	(BMCNs)	account	for	less	than	5%	of	liver	cysts	and	as	more	
incidental	simple	cysts	are	identified	on	imaging,	the	ratio	is	likely	to	decline.3	The	first	
account	of	an	intrahepatic	biliary	cystadenoma	was	published	in	1887	with	the	first	
resection	performed	in	1892.4	This	literature	review	aims	to	describe	the	evolution	in	
interpretation	of	the	histopathological	features,	to	outline	the	diagnostic	features	in	the	
context	of	the	differential	diagnosis	and	to	detail	management	of	these	uncommon	
tumours.	
	
Definition	and	classification	
In	1958	Edmondson	defined	strict	criteria	for	the	diagnosis	of	biliary	cystadenoma,	namely	
the	presence	of	ovarian-like	stroma	(OS)	surrounding	a	multilocular	cystic	liver	lesion.4	In	
1994	Devaney	et	al.	noted	in	a	pathological	review	of	70	cases	that	the	presence	of	OS	was	
inconsistent	and	suggested	that	biliary	cystadenomas	may	occur	with	or	without	OS	being	
present.5	In	2000	the	World	Health	Organization	defined	the	terms	biliary	cystadenoma	and	
cystadenocarcinomas	to	describe	the	benign	and	malignant	components	of	the	disease	
entity.6,7	The	classification	was	revised	in	2010	suggesting	the	following	definition:	
“Mucinous	cystic	neoplasms	(MCNs)	are	cyst-forming	epithelial	neoplasms,	usually	with	no	
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communication	with	the	bile	ducts,	composed	of	cuboidal	to	columnar	epithelium	with	
variable	mucin	production	and	associated	with	ovarian-type	sub-epithelial	stroma.”	BMCNs	
are	subdivided	into	non-invasive	and	invasive	(previously	known	as	biliary	cyst-
adenocarcinoma).8,9	The	neoplasms	without	OS	are	classified	as	intraductal	papillary	
neoplasms	(IPNs)	of	the	bile	ducts	with	marked	cystic	changes.	As	bile	duct	communication	
which	is	required	for	defining	IPNs	is	seldom	present,	this	classification	is	still	incomplete.	
Neoplasms	without	OS	and	BDC	do	not	fit	into	either	description.	The	nomenclature	is	
summarized	in	Table	1.	Consensus	has	not	been	reached	and	there	are	still	numerous	
reports	of	cystadenomas	without	OS	and	the	nomenclature	of	the	2000	WHO	classification	
is	still	widely	used.
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Table	1.	Comparison	World	Health	Organization	(WHO)	classification	of	mucinous	cystic	liver	neoplasms6,8,10	
	
WHO	2000	
Prior	nomenclature	
WHO	2010	
Current	nomenclature	
	
Key	Features	
Biliary	cystadenoma	
	
Non-invasive	biliary	mucinous	cystic	neoplasm	
(ni-BMCN)	
Needs	ovarian-like	stroma	
No	bile	duct	communication	
Biliary	cystadenocarcinoma	 Invasive	biliary	mucinous	cystic	neoplasm	
(i-BMCN)	
Needs	ovarian-like	stroma	
No	bile	duct	communication	
Not	previously	classified	 Intraductal	papillary	mucinous	neoplasm	–	biliary	type	
(IPMN-B)	
No	ovarian-like	stroma	
Needs	bile	duct	communication	
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Figure	2.	Pathological	diagnostic	algorithm	for	epithelium	lined	cystic	liver	lesions	(Adapted	from:	WHO	Classification	of	Tumours	of	the	
Digestive	System,	Fourth	Edition)8	
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Pathology	
BMCNs	occur	as	large	solitary,	multiloculated	complex	cysts	with	internal	septations	and	
mural	nodularity,	surrounded	by	a	dense	cellular	fibrostroma.11,12	Size	varies	from	2cm	to	
40cm	at	presentation,	with	mean	sizes	of	around	15cm	being	reported.3,13,14	The	majority	of	
cysts	are	centrally	located	in	the	liver	but	may	occur	in	the	right	or	left	hemi-livers.9	
BMCNs	are	usually	globular,	with	a	smooth	external	surface	and	a	smooth	or	trabeculated	
inner	lining.	The	cyst	usually	contains	clear	mucinous	fluid	but	may	be	bile	stained,	even	in	
the	absence	of	a	distinct	biliary	communication.12,15	BMCNs	are	characterized	by	three	
histological	layers,	namely:15-17	
• an	inner	biliary-type	epithelial	layer	containing	cuboidal	to	columnar	cells	which	may	
produce	mucin;	
• a	layer	of	dense	undifferentiated	mesenchymal	cells	resembling	OS	deep	to	the	
epithelial	lining;	the	stromal	cells	are	spindle-shaped	and	usually	immunoreactive	with	
vimentin,	alpha-smooth	muscle	actin	and	less	frequently	estrogen	and	progesterone	
receptors;	
• a	dense	outer	collagenous	layer,	consisting	of	connective	tissue,	separates	the	cyst	from	
liver	parenchyma	and	often	provides	a	surgical	plane	for	enucleation.	
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Clinical	presentation	
The	vast	majority	of	BMCNs	occur	in	women.	This	female	predominance	suggests	a	
hormonal	influence.18	The	age	at	presentation	varies	but	the	peak	occurs	in	the	4th	and	5th	
decades.19	Patients	may	be	asymptomatic	with	the	cystic	lesion	discovered	incidentally	on	
imaging	or	during	surgery	for	other	indications.20-22	Symptomatic	patients	present	with	an	
insidious	onset	of	symptoms	due	to	the	slow	growing	nature	of	the	tumour.12,19	Vague	
upper	abdominal	pain	and	fullness	are	common	presenting	symptoms.23	It	may	be	
accompanied	by	dyspepsia,	anorexia,	nausea	and	a	palpable	abdominal	mass.24	Jaundice	
due	to	biliary	obstruction	caused	by	compression	of	the	tumour	is	uncommon.25	
Complications,	for	example	cyst	rupture,	bacterial	infection,	intracystic	haemorrhage	and	
inferior	vena	cava	obstruction	are	rare.26-28	In	Table	2	key	clinical	and	biochemical	features	
that	may	aid	in	characterizing	cystic	lesions	of	the	liver	are	presented.	
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Table	2.	Clinical	and	biochemistry	characteristics	of	the	most	common	cystic	lesions	of	the	liver10	
	
	
	
	
	
	
	
	
	
	
	
	
	
RUQ:	Right	upper	quadrant
Cystic	lesion	 Demography	 Clinical	picture	 Blood/cyst	fluid	analyses	
Non-infective	 	 	 	
Simple	cyst	 Non	specific	 Vague	RUQ	pain	
Incidental	
Non	specific	
Biliary	MCN	
		
Middle	age	females	
	
Epigastric	or	RUQ	pain	
Palpable	mass		
Could	be	asymptomatic	
Non	specific	
Unlike	MCNs	of	pancreas,	aspiration	not	helpful	
Polycystic	disease	 Genetic	predisposition	
	
Generally	asymptomatic	
RUQ	pain	
Renal	dysfunction	if	kidneys	involved	
Biliary	hamartoma	
(Von	Meyenburg	complex)	
Non	specific	
	
Mostly	asymptomatic		
Incidental	
Non	specific	
Caroli’s	disease	 Congenital	disease	
	
Recurrent	attacks	of	RUQ	pain	
Cholangitis	
Non	specific	
Infective	/	Parasitic		 	 	 	
Hydatid	(echinococcal	cyst)	 Endemic	area	
	
Asymptomatic	or	RUQ	pain		
Hepatomegaly		
Occasionally	jaundice	
Positive	serology	
(False	negative	in	20%)	
	
Pyogenic	abscess	 Abdominal	sepsis	
Biliary	intervention	
IV	drug	users	
	
Pyrexia	and	rigors	
Severe	RUQ	pain	
Weight	loss	
Systemically	unwell	
Elevated	infective	markers	(WCC)	
Positive	cyst	and/or	blood	cultures	
Amoebic	abscess	 Endemic	area	 High	fever	
Severe	RUQ	pain	
ELISA	positive	(90%	sensitivity)	
Typical	“anchovy	paste”	appearance	of	abscess	content	
	 17	
Special	investigations	
Liver	function	tests	are	usually	normal,	but	elevated	bilirubin,	alkaline	phosphatase	(ALP)	
and	gamma-glutamyl	transpeptidase	(GGT)	may	occur	with	intra-	or	extrahepatic	biliary	duct	
compression.9	Serum	tumour	markers	are	of	limited	diagnostic	value.	Wang	et	al.	found	in	a	
series	of	30	patients	that	carbohydrate	antigen	19-9	(CA	19-9)	was	elevated	in	only	57.1%	of	
the	cases.13	If	hydatid	disease	is	suspected,	full	blood	count,	serology	and	immunological	
testing	may	be	helpful.29	 Unlike	carcinoembryonic	antigen	(CEA)	and	CA	19-9,	a	tumour-
associated	glycoprotein	72	(TAG	72)	concentration	of	more	than	25	units/ml	differentiated	
hepatic	simple	cysts	from	mucinous	cysts	with	a	sensitivity	and	a	specificity	of	0,79	and	0,97	
respectively	in	a	recent	study	of	27	mucinous	liver	cysts.30	However,	TAG	72,	also	known	as	
CA	72-4	is	not	universally	available	and	the	results	of	this	small	cohort	has	not	been	
replicated.	Fine	needle	aspiration	and	cyst	fluid	analysis	have	thus	not	been	proven	to	
influence	the	management	and	may	be	potentially	harmful	in	that	malignant	cells	may	
dessiminate	in	patients	with	an	invasive	BMCN.12,14	
Differentiating	BMCNs	from	other	cystic	lesions	in	the	liver	are	primarily	imaging-based.12,31	
Ultrasound	(US),	computed	tomography	(CT)	and	magnetic	resonance	imaging	(MRI)	
characteristics	of	the	most	common	cystic	liver	lesions	are	shown	in	Table	3.	US	may	be	able	
to	confidently	diagnose	BMCNs	if	the	characteristic	findings,	a	well-demarcated,	mostly	
multilocular	hyperechogenic	mass,	which	may	have	septae	and	with	characteristic	papillary	
projections	from	the	cyst	wall	are	present.9	It	is	particularly	helpful	in	distinguishing	BMCNs	
from	simple	cysts,	typically	well	demarcated	with	anechoic	unilocular	fluid-filled	spaces	with	
imperceptible	walls	and	posterior	acoustic	enhancement	and	hydatid	liver	disease	especially	
in	the	presence	of	daughter	cysts,	hydatid	sand	and	typical	septae.32	
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CT	and	MRI	are	useful	for	more	accurate	characterization	of	lesions.	Common	BMCN	
features	on	CT	include	low-density,	well	defined,	lobulated,	multilocular,	thick-walled	cystic	
lesions	with	internal	septa	and	occasionally	mural	nodules.9,14	The	presence	of	intrahepatic	
or	extrahepatic	bile	duct	dilatation	is	usually	also	evident.	Mild	central	intrahepatic	dilation	
is	often	a	feature	of	BMCNs,	due	to	compression	of	the	bile	duct.33	
On	MRI	BMCNs	are	typically	well-defined	lesions	that	do	not	enhance	after	the	
administration	of	intravenous	gadolinium.	On	T1-weighted	sequences	the	cysts	show	low	
signal	intensity,	whereas	on	T2	weighted	sequences	a	very	high	intensity	signal	is	seen.	
However,	no	MRI	parameters	can	confidently	predict	the	presence	of	OS.32	Cross-sectional	
imaging	furthermore	allows	better	morphological	assessment	and	orientation,	including	
appraisal	of	segmental	engagement	of	the	lesion	as	well	as	determining	proximity	to	vital	
vascular	and	biliary	structures,	information	that	is	crucial	for	optimal	surgical	planning.34	
US,	CT	or	MRI	findings	cannot	reliably	distinguish	non-invasive	from	invasive	BMCNs	and	all	
lesions	should	be	treated	as	potentially	malignant.35-37	
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Table	3.	US,	CT	and	MRI	characteristics	of	the	most	common	cystic	liver	lesion10
Cystic	lesion	 US	 CT	 MRI	\	MRCP	
Simple	cyst	 Single	or	multiple	
Well	circumscribed	anechoic	structure	with	
enhancement	of	the	posterior	wall	
Well-defined	
Attenuation	(0–15	HU)	similar	to	water	
No	enhancement	with	contrast	
Well-defined	
T1:	hypointense	
T2:	hyperintense	
Biliary	MCN	 Single	
Anechoic	mass	with	occasional	internal	septations	
or	papillary	projections	
Complex	solitary	well-defined,	multilocular	
Occasional	upstream	bile	duct	dilatation	
Internal	septations,	enhancement	of	walls	
Multilocular	mass	
Septated	
Homogeneous	high	(T2)	signal	intensity	
Polycystic	disease	 Multiple	
Hypoechoic	
Thin-walled	cysts	of	varying	sizes	
Multiple	simple	cysts	 T1:	Very	low	signal	intensity	
T2:	Homogeneous	high	signal	intensity	
Biliary	hamartoma	
(Von	Meyenburg	
complex)	
Multiple	
Variable	because	of	the	small	lesion	size	
Multiple,	small	(<	15	mm),	round	or	
irregular	scattered	cysts	
Predilection	for	the	subcapsular	region	
Multiple,	tiny	cystic	lesions	with	irregular	
borders	
MRCP	-	no	biliary	communication	
Caroli’s	disease	 Multiple	of	varying	size	
Dilated	cystic	structures	which	communicate	with	
the	biliary	tree	
Cystic	and	usually	have	a	central	enhancing	
component,	the	“central	dot”	sign	
MRCP	-	demonstrates	communication	
between	the	Caroli’s	cysts	and	the	biliary	
tee	
Hydatid	
(echinococcal	cyst)	
Single	or	multiple	
Purely	cystic	to	solid-appearing	lesions	
Daughter	cyst	or	echogenic	debris	
Well-defined,	hypo-attenuating	lesion	with	
a	distinguishable	wall	
Daughter	cyst	identified	in	majority	
Calcification	in	mature	cysts	
T2	sequence:	
Pericyst	has	a	hypointense	rim	
Hydatid	debris	is	markedly	hyperintense	
Daughter	cysts	are	hypointense	
Pyogenic	abscess	 Single	or	multiple	
Anechoic	mass	with	well-defined	or	indistinct	
borders	and	may	possibly	contain	echogenic	debris	
or	gas	
Iso-	to	hypo-attenuating	compared	with	
background	liver	on	the	unenhanced	phase	
Peripheral	rim	of	enhancement	
Variable	signal	intensity	
Peri-lesional	oedema	
Amoebic	abscess	 Single	or	multiple	
Hypoechoic	round	or	oval	lesions	
Show	low-level	internal	echoes	and	posterior	
acoustic	enhancement	
Slightly	higher	attenuation	than	water	
Smooth	or	nodular	borders	
Thick	wall	that	typically	enhances	
The	central	portion	appears	cystic	
The	ring	exhibits	variable	intensities	on	T1-	
and	T2-weighted	imaging	
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Treatment	
The	prerequisite	for	optimal	management	of	BMCNs	is	accurate	pre-operative	diagnosis.	A	
BMCN	misdiagnosed	as	a	simple	cyst	and	treated	as	such,	usually	aspiration	or	deroofing,	
will	recur.	The	mainstay	of	treatment	for	BMCNs	is	complete	resection.	Incomplete	
resection	will	result	in	recurrence,	requiring	re-operation	with	the	morbidity	associated	with	
re-operation.9,14	Techniques	such	as	aspiration,	internal	drainage,	intracystic	sclerosant	
injection	and	incomplete	resection	have	recurrence	rates	of	90-100%.38,39	In	the	largest	
single	centre	series	to	date,	Chen	et	al.	reported	treatment	and	outcome	in	39	patients.	All	
patients	were	treated	surgically,	seven	of	whom	were	incorrectly	diagnosed	before	surgery.	
These	included	four	patients	in	whom	the	cysts	were	diagnosed	as	simple	hepatic	cysts,	two	
diagnosed	as	abscesses	and	one	diagnosed	as	intrahepatic	bile	duct	stones.	Liver	resection	
was	performed	in	17	patients	(eight	right	and	nine	left	hemi-hepatectomies)	and	
enucleation	was	performed	in	22	patients.	In	all	patients	with	pre-operative	symptoms	the	
symptoms	resolved	after	surgery.	There	were	no	major	complications	or	mortalities.	At	a	
median	of	20	months	follow	up	one	patient	presented	with	recurrence.24		
Thomas	et	al.	describe	two	patients	with	large	BMCNs	in	whom	fenestration	and	complete	
fulguration	was	used	successfully.	In	one	patient	with	an	invasive	BMCN,	a	formal	resection	
of	the	main	lesion	was	performed	and	a	satellite	lesion	was	unroofed	with	fulguration	of	the	
internal	cystic	lining	with	argon	beam	coagulation.	The	other	patient	with	a	16	cm	lesion	in	
the	right	liver	underwent	laparoscopic	exploration	with	fenestration	and	fulguration	of	the	
cyst	bed.	Neither	of	the	patients	developed	recurrent	disease	at	five	and	one	years	follow-
up	respectively.	The	series,	however,	is	too	small	to	recommend	this	as	a	routine	treatment	
method,	but	could	be	an	option	for	BMCNs	in	difficult	anatomical	positions.40	
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Koffron	et	al.	proposed	a	laparoscopic	approach	to	BMCNs	after	successfully	treating	22	
patients	laparoscopically	with	only	one	recurrence	on	a	mean	16	months	follow-up.	
Cognizant	of	previous	reports	of	recurrence	after	fenestration	and	marsupialization,	the	
authors	performed	the	widest	possible	marsupialization	in	patients	where	complete	
resection	was	precluded	by	proximity	to	central	biliary	structures	or	large	vessels.	In	the	11	
patients	treated	in	this	fashion	the	small	portion	of	the	remaining	cyst	wall	was	left	
untreated.	The	short	follow-up	in	the	study,	however,	is	of	concern.41	
There	is	a	single	case	report	of	a	transplant	for	a	symptomatic	BMCN	that	involved	the	
central	biliary	and	vascular	structures.	An	unsuccessful	attempt	at	resection	resulted	in	a	
non-reconstructable	intrahepatic	biliary	injury	that	warranted	a	transplant.42	
Complete	surgical	resection	with	negative	margins	remains	the	recommended	
treatment.43,44	This	is	achieved	by	formal	liver	resection	for	peripheral	lesions	and	those	
limited	to	a	hemi-liver	or	enucleation	in	centrally	located	lesions	that	involve	vital	vascular	
and/or	biliary	structures.	A	laparoscopic	approach	is	acceptable	but	should	not	be	pursued	
relentlessly	at	the	cost	of	a	non-radical	resection.	
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Prognosis	
The	prognosis	in	completely	resected	BMCNs	is	excellent,	with	10	year	survival	approaching	
100%.9	Recurrences	after	completele	resection	of	cysts	are	seen	in	less	than	10%	of	
patients.4,24	Older	age,	male	gender	and	shorter	duration	of	symtoms	on	presentation	are	
associated	with	a	higher	possibility	of	invasive	BMCNs.13	All	patients	should	be	followed	up	
after	resection	for	BMCNs	with	abdominal	ultrasound.	There	are	no	clear	guidelines	or	
consensus	on	follow-up	regarding	the	modality	and	frequency.	In	patients	who	would	be	
candidates	for	re-intervention	most	authors	suggest	follow	up	with	non-radiation	modalities	
(US	or	MRI)	at	6	to	12	month	intervals	for	a	duration	of	3	to	5	years.14,15,23,40,45	
Summary	and	future	perpectives	
BMCNs	are	complex	liver	lesions	and	should	be	considered	in	middle	aged	women	who	have	
well	encapsulated	multilocular	cystic	liver	tumours.	While	the	histologic	classification	has	
evolved	considerably,	further	refinements	are	required,	specifically	addressing	the	issue	of	
lesions	without	OS.	This	should	resolve	some	of	the	current	controversies	and	will	facilitate	
standardized	reporting.	Complete	surgical	resection,	although	often	complex	due	to	central	
location	of	lesions,	provides	curative	treatment.	Due	to	the	unpredictable	malignant	risk	
and	tendency	for	late	recurrence	patients	with	BMCNs	need	careful	long-term	follow	up.	
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Abstract:	
	
Background:	Biliary	mucinous	cystic	neoplasms	(BMCNs)	are	uncommon	neoplastic	
septated	intrahepatic	cysts	which	are	often	incorrectly	diagnosed	and	have	the	potential	for	
malignant	transformation.	
Aim:	The	aim	of	this	study	was	to	assess	the	outcome	of	surgical	resection	of	BMCNs.	
Methods:	Data	from	a	departmental	and	faculty	registered	prospective	liver	surgery	
database	was	used	to	identify	patients	who	underwent	surgery	at	Groote	Schuur	and	the	
University	of	Cape	Town	Private	Academic	Hospitals	for	BMCN	from	1999	to	2015.	Standard	
demographic	variables	including	age	and	gender	were	documented	as	well	as	detailed	pre-
operative	imaging,	location	and	size,	operative	treatment,	extent	of	resection,	histology,	
post-operative	complications	using	the	Clavien-Dindo	classification	and	long-term	outcome.	
Results:	Thirteen	female	patients	(median	age	45	years)	had	surgery.	Eleven	were	diagnosed	
by	computer	tomography	scan	after	investigation	of	abdominal	pain	or	a	palpable	mass.	
Two	were	jaundiced.	One	cyst	was	found	incidentally	during	an	elective	cholecystectomy.	
Five	cysts	were	located	centrally	in	the	liver.	Before	referral	three	cysts	were	treated	
inappropriately	with	percutaneous	aspiration	or	drainage	and	two	were	treated	with	
operative	deroofing.	Six	patients	had	anatomical	liver	resections	and	seven	patients	had	non	
anatomical	liver	resections	of	which	two	needed	ablation	of	residual	cyst	wall.	One	patient	
needed	a	biliary-enteric	reconstruction	to	treat	a	fistula	of	the	left	hepatic	duct.	Median	
operative	time	was	183	minutes	(range:	130-375).	No	invasive	carcinoma	was	found	on	
histology.	There	was	no	operative	mortality.	One	surgical	site	infection	was	treated	and	one	
patient	developed	an	intra-abdominal	collection	one	month	post-operatively.	Two	patients	
developed	recurrent	BMCN	after	24	months.	
Conclusion:	BMCNs	should	be	considered	in	middle	aged	women	who	have	well	
encapsulated	multilocular	liver	cysts.	Treatment	of	large	central	BMCNs	adjacent	to	vascular	
and	biliary	structures	in	particular	may	require	technically	complex	liver	resections	and	are	
best	managed	in	a	specialized	hepato-pancreatico-biliary	unit
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Introduction	
Biliary	mucinous	cystic	neoplasms	(BMCNs)	are	uncommon	multilocular	hepatic	cysts	which	
account	for	less	than	5%	of	liver	cysts.1	BMCNs	are	often	incorrectly	diagnosed	and	have	the	
potential	for	malignant	transformation.2	Clear	guidelines	are	scant	and	publications	are	
limited	to	small	case	series	of	BMCNs.3,4	Most	occur	in	middle-aged	women.	Patients	may	
be	asymptomatic	and	the	tumours	are	often	discovered	incidentally	during	imaging	or	at	
laparotomy.	Management	is	complicated	because	accurate	identification	of	the	invasive	
form	before	surgery	is	seldom	possible.	The	potential	for	malignant	transformation	and	the	
tendency	to	recur,	particularly	when	treated	with	techniques	other	than	complete	excision,	
are	of	concern	in	these	tumours.	In	this	study,	we	describe	the	surgical	treatment	of	13	
patients	with	BMCNs	from	a	single	tertiary	center.	
	
Materials	and	Methods	
A	retrospective	analysis	of	a	prospectively	maintained	database	of	all	liver	surgery	at	Groote	
Schuur	and	the	University	of	Cape	Town	Private	Academic	Hospitals	between	1999	and	2015	
was	performed	to	identify	all	patients	with	a	histological	confirmed	BMCN,	based	on	the	
WHO	diagnostic	criteria.5	Patient	demographics,	clinical	presentation	and	detailed	pre-
operative	imaging	characteristics	of	the	tumour,	including	intrahepatic	location	were	
recorded.	The	extent	of	the	surgical	procedure	was	detailed	and	included	operative	time	
and	blood	transfusion	requirements.	Post-operative	complications	were	documented	
according	to	the	Clavien-Dindo	(CD)	classification.6	Patients	were	planned	for	routine	six	
monthly	follow	up.	Initial	surveillance	investigation	was	abdominal	ultrasound	and	
additional	investigations,	for	example	CT	or	MRI	were	performed	as	clinically	indicated.	
Descriptive	analyses	were	used	to	characterize	the	study	population.	The	registry	for	liver	
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resections	(R024/2014)	and	the	analysis	of	this	subgroup	(735/2016)	were	approved	by	the,	
Faculty	of	Health	Sciences	Human	Research	Ethics	Committee	of	the	University	of	Cape	
Town.	
	
Results	
During	the	study	period	457	liver	resections	were	performed	of	which	13	were	for	BMCN.	
All	13	were	females	with	a	median	age	of	45	years	(range	22-74).	The	clinical	characteristics	
are	summarized	in	Table	1.	Ten	patients	presented	with	abdominal	pain,	eight	had	a	
palpable	mass	and	two	were	jaundiced.	In	12	patients	the	presumptive	diagnosis	was	made	
on	preoperative	imaging	(CT=11,	US	=	1)	while	one	cyst	was	found	incidentally	during	an	
elective	laparoscopic	cholecystectomy	(Figure	1).	Median	cyst	size	was	13	cm	(range	2.5-30	
cm)	and	most	occurred	centrally	in	the	liver,	abutting	the	hilar	bilio-vascular	structures.	
Three	patients	had	percutaneous	aspiration	of	cysts	before	referral.	In	two	patients	
inappropriate	deroofing	was	performed	before	referral.	In	one,	treated	as	a	simple	cyst,	
histology	confirmed	a	BCMN,	while	in	the	other	a	persistent	bile	leak	after	deroofing	
required	a	formal	liver	resection.	
The	operative	technique	and	procedure	were	adapted	to	the	cyst	size	and	location	and	
proximity	of	the	cyst	to	vital	structures	in	the	porta	hepatis,	the	hepatic	veins	and	the	
inferior	vena	cava	(Table	2)	(Figure	2).	In	two	patients	in	whom	the	back	wall	of	the	BCMN	
was	adherent	to	major	vascular	structures,	as	much	of	the	cyst	wall	as	could	be	safely	
resected	was	removed	and	the	residual	inner	cyst	surface	was	ablated	with	argon	beam	
coagulation.	In	one	patient	with	a	complex	centrally	located	cyst	in	whom	the	left	hepatic	
duct	communicated	with	the	cyst	cavity,	a	biliary-enteric	reconstruction	with	a	Roux-en-Y	
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loop	was	performed.	Four	patients	had	bile	leaks	identified	during	surgery	that	were	
oversewn.	Two	patients	had	postoperative	complications.	In	one	patient	a	CD	grade	II	
surgical	site	infection	was	successfully	treated	with	antibiotics	and	in	the	other	a	grade	IIIa	
intra-abdominal	collection	required	radiological	percutaneous	drainage	one	month	after	
surgery.	Four	patients	had	frozen	section	performed	on	the	cyst	wall	intra-operatively,	all	
confirming	mucinous	neoplasms.	None	of	the	patients	had	invasive	BCMN	on	histology	
(Figure	3).	
All	patents	had	a	follow-up	visit	after	surgery,	but	long	term	follow-up	more	than	1	month	
was	only	possible	in	7	patients	with	a	median	follow	up	of	12	months	(range	1-24	months).	
Two	patients	developed	recurrent	disease	after	24	months.	Both	recurrences	presented	
with	symptoms	which	triggered	cross	sectional	imaging.	One	recurred	after	partial	resection	
with	ablation	of	the	remnant	cyst	wall	and	declined	further	surgery.	The	other	who	recurred	
after	a	formal	resection	was	treated	with	percutaneous	aspiration	and	ethanol	injection	
because	of	a	high	operative	risk.	She	remains	symptom	free	after	eight	years.		 	
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Table	1.	Clinical	characteristics	of	patients	
Patient	 Age	 Symptoms	 Clinical	Signs	
Maximum	
diameter	(cm)	
Location	
(segments)	
1	 46	 RUQ	pain	 Jaundice	and	epigastric	mass	 15	 Central	(4,5)	
2	 47	 N	and	V,	LOW	 Palpable	epigastric	mass	 25	 Right	(5,6)	
3	 39	 RUQ	pain	 None	 2,5	 Right	(5)	
4	 48	 Epigastric	discomfort	 Palpable	epigastric	mass	 NA	 Central	(2,3,4,5)	
5	 74	 Epigastric	discomfort	 None	 NA	 Left	(2,3)	
6	 22	 RUQ	pain	 Jaundice	and	epigastric	mass	 12	 Central	(4,5)	
7	 32	 Biliary	colic	 None	 10	 Left	(3)	
8	 45	 Abdominal	distention	 Palpable	epigastric	mass	 21	 Central	(4,5,6)	
9	 35	 RUQ	pain	 Previous	surgery	 8	 NA	
10	 56	 RUQ	pain	 Palpable	epigastric	mass	 10	 Right	(5)	
11	 44	 Epigastric	discomfort	 NA	 NA	 Right	(5,6)	
12	 38	 Abdominal	distention	 Palpable	epigastric	mass	 30	 Central	(4,5,8)	
13	 63	 Epigastric	discomfort	 Palpable	epigastric	mass	 14	 Left	(2,3)	
RUQ:	right	upper	quadrant;	N	and	V:	nausea	and	vomiting;	LOW:	loss	of	weight;	NA:	not	available	
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Table	2.	Operative	procedures	(n	=	13)	
	
	 Operation	
	 	 Anatomical	liver	resection		 	 	 	 6	
	 	 Non-anatomical	liver	resection	
	 	 	 Complete	 	 	 	 	 5	
	 	 	 Incomplete	resection	with	ablation		 	 2	
	 Inflow	occlusion	 	 	 	 	 	 	 2	
	 Intra-operative	blood	transfusion	 	 	 	 	 1	
	 Intra-operative	frozen	section	performed	 	 	 	 4	
	 Drain	 	 	 	 	 	 	 	 11	
	 Operative	time	(minutes),	median	(range)	 	 	 	 183	(130-375)	
	 ICU	stay	(days),	median	(range)	 	 	 	 	 2	(1-3)	
	 Hospital	stay	(days),	median	(range)	 	 	 	 7	(5-8)	
	
	
Figure	 1.	CT	 axial	 image	of	 patient	 8	 demonstrated	 a	 typical	 central	 placed	 complex	 liver	
cyst	
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Figure	2.	Operative	picture	of	BMCN	before	resection	
	
	
	
	
	
Figure	3.	Low	and	high	power	histology	slides	of	a	BMCN	wall	with	the	arrow	indicating	the	
ovarian-like	stroma	
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Discussion	
In	this	study	all	patients	were	females	with	a	median	age	of	45	years	which	is	in	keeping	
with	the	literature	that	reports	a	female	BCMN	preponderance	of	90%,	typically	in	the	
fourth	and	fifth	decades	of	life.7	The	majority	of	patients	presented	with	cyst-related	
symptoms	as	summarized	in	table	1.	Some	BMCNs	in	our	series	were	mistaken	for	simple	
cysts	which	led	to	inappropriate	initial	treatment,	including	aspiration	and	deroofing.	
Patients	with	incomplete	initial	resection	develop	recurrent	symptoms	and	are	at	risk	for	
malignant	transformation,	and	thus	require	definitive	surgery	for	complete	resection.2,8	
Older	age,	male	gender	and	shorter	duration	of	symtoms	on	presentation	are	associated	
with	a	greater	risk	of	invasive	BMCN.9		
Abdominal	ultrasound	typically	shows	well-demarcated,	mostly	multilocular	hyperechogenic	
cystic	lesions,	which	may	show	septae	and	characteristic	papillary	projections	from	the	cyst	
wall.10	As	in	our	patients,	common	features	on	CT	include	low-density,	well	defined,	
lobulated,	multilocular,	thick-walled	cystic	lesions	with	internal	septa	and	occasionally	mural	
nodules.5,10	CT	also	provides	additional	information	regarding	the	anatomic	relation	of	cysts	
to	major	vessels	and	bile	ducts	as	well	as	surrounding	structures.	MRI/MRCP	may	be	of	
value	in	assessing	proximity	to	the	intrahepatic	biliary	system	and	possible	biliary	
communication	of	cysts.11	In	most	of	our	patients	the	typical	imaging	findings	of	a	large,	
solitary	multiloculated	complex	liver	cyst	with	internal	septation	and	nodularity	was	
present.	Most	cysts	occurred	centrally	in	the	liver,	straddling	right	and	left	lobes	and	in	close	
relation	to	the	porta	hepatis.	
Serum	markers	were	not	routinely	done	to	aid	with	the	diagnosis	in	our	series,	which	is	in	
keeping	with	the	results	of	Wang	et	al.	who	in	a	series	of	30	patients	found	that	CA	19-9	to	
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be	elevated	in	only	17	patients.12	CA	19-9	was	available	in	four	patients	of	our	patients	with	
only	one	being	elevated.	Fine	needle	aspiration	with	cyst	fluid	analysis	was	not	used	in	this	
current	study	because	of	potential	harm	in	disseminating	malignant	cells	and	has	not	been	
proven	to	change	the	management	plan.11		
As	in	our	study	only	a	minority	of	patients	present	with	complications	such	as	jaundice,	cyst	
rupture,	bacterial	infection	or	intracystic	hemorrhage.	Rare	complications	such	as	biliary	
fistulae	and	inferior	vena	cava	obstruction	have	been	described.4	Although	all	the	patients	
in	this	study	had	benign	features	on	histology,	malignant	change	has	been	reported	in	up	to	
10%	of	patients.13	
The	only	appropriate	surgical	strategy	for	treatment	of	BMCNs	is	complete	resection	with	
negative	margins,	either	as	anatomical	or	non-anatomical	liver	resection,	depending	on	the	
position	of	the	cyst	and	the	relationship	to	vital	structures.	The	complexity	of	management	
is	illustrated	in	a	global	multi-centre	analysis	of	248	patients	in	which	10%	of	patients	had	
malignant	transformation	to	cystadenocarcinoma	and	18.3%	recurred	after	inadequate	
surgery.13	In	the	largest	single-centre	cohort	of	39	patients	seven	were	misdiagnosed	before	
initial	surgery.	Liver	resection	was	performed	in	17	patients	(eight	right	and	nine	left	hemi-
hepatectomies)	and	enucleation	was	performed	in	22	patients.	At	a	median	follow-up	of	20	
months	one	patient	presented	with	recurrence.3	In	our	series	six	patients	had	anatomical	
resections	and	seven	had	non-anatomical	resections	while	two	of	these	needed	ablation	of	
residual	cyst	wall	(Table	2).	Alternative	techniques	such	as	aspiration,	internal	drainage,	
intratumoral	sclerosant	application	and	incomplete	resection	result	in	recurrence	rates	of	
90	to	100%.	Intra-operative	frozen	section	of	the	cyst	wall	has	not	been	shown	to	alter	the	
operative	procedure	as	the	biopsy	could	be	non-representative.14	There	is	a	single	case	
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report	of	a	liver	transplant	for	a	central	symptomatic	BMCN	involving	the	main	
vasculobiliary	structures.15		
As	in	our	series,	the	short-term	operative	morbidity	in	published	series	is	low	and	the	
prognosis	in	completely	resected	BMCNs	is	excellent.1,12,16	Even	though	recurrence	after	an	
adequately	treated	cysts	is	less	than	five	percent,	follow-up	with	abdominal	ultrasound	after	
resection	is	recommended.	
Conclusion	
BMCNs	should	be	considered	in	middle	aged	women	who	have	well	encapsulated	
multilocular	liver	cysts.	Treatment	of	large	central	BMCNs	adjacent	to	vascular	and	biliary	
structures	in	particular	may	require	technically	complex	and	challenging	liver	resections	and	
are	best	managed	in	a	specialized	hepato-pancreatico-biliary	unit.	
Conflicts	of	interest	
The	authors	declare	no	conflict	of	interest.	
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